Impact of Baseline Kidney Dysfunction on Oral Diuretic Efficacy Following Hospitalization for Heart Failure – Insights from TRANSFORM-HF
European Journal of Heart Failure · 01.05.2024 · 26 (5) · 1242-1250
DOI: 10.1002/ejhf.3207 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Heart Failure, online erschienen am 01.04.2024. Verfasst von Pieter Martens und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Ziekenhuis Oost-Limburg A.V., Genk, Belgium. Hauptthemen laut MEDLINE: Heart Failure, Hospitalization, Furosemide, Glomerular Filtration Rate. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aim
Among patients discharged after hospitalization for heart failure (HF), a strategy of torsemide versus furosemide showed no difference in all-cause mortality or hospitalization. Clinicians have traditionally favoured torsemide in the setting of kidney dysfunction due to better oral bioavailability and longer half-life, but direct supportive evidence is lacking. Methods and results The TRANSFORM-HF trial randomized patients hospitalized for HF to a long-term strategy of torsemide versus furosemide, and enrolled patients across the spectrum of renal function (without dialysis). In this post-hoc analysis, baseline renal function during the index hospitalization was assessed as categories of estimated glomerular filtration rate (eGFR; <30, 30–<60, ≥60 ml/min/1.73 m2). The interaction between baseline renal function and treatment effect of torsemide versus furosemide was assessed with respect to mortality and hospitalization outcomes, and the change in Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS). Of 2859 patients randomized, 336 (11.8%) had eGFR <30 ml/min/1.73 m2, 1138 (39.8%) had eGFR 30–<60 ml/min/1.73 m2, and 1385 (48.4%) had eGFR ≥60 ml/min/1.73 m2. Baseline eGFR did not modify treatment effects of torsemide versus furosemide on all adverse clinical outcomes including individual components or composites of all-cause mortality and all-cause (re)-hospitalizations, both when assessing eGFR categorically or continuously (p-value for interaction all >0.108). Similarly, no treatment effect modification by eGFR was found for the change in KCCQ-CSS (p-value for interaction all >0.052) when assessing eGFR categorically or continuously.
Conclusion
Among patients discharged after hospitalization for HF, there was no significant difference in clinical and patient-reported outcomes between torsemide and furosemide, irrespective of renal function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Ziekenhuis Oost-Limburg A.V., Genk, Belgium.
- Kaufman Center for Heart Failure Treatment and Recovery, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
- Duke Clinical Research Institute, Durham, NC, USA.
- Department of Medicine, University of Utah, Salt Lake City, UT, USA.
- Department of Medicine, University of Mississippi, Jackson, MS, USA.
- Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
Zitieren
APA
Martens, P., Greene, S. J., Mentz, R. J., Li, S., Wojdyla, D., Kapelios, C. J., Mullens, W., Hall, M. E., Ketema, F., Kim, D. Y., Eisenstein, E. L., Anstrom, K., Fang, J. C., Pitt, B., Velazquez, E. J., & Tang, W. H. W. (2024). Impact of Baseline Kidney Dysfunction on Oral Diuretic Efficacy Following Hospitalization for Heart Failure – Insights from TRANSFORM-HF. European Journal of Heart Failure, 26(5), 1242-1250. https://doi.org/10.1002/ejhf.3207
Vancouver
Martens P, Greene SJ, Mentz RJ, Li S, Wojdyla D, Kapelios CJ, et al. Impact of Baseline Kidney Dysfunction on Oral Diuretic Efficacy Following Hospitalization for Heart Failure – Insights from TRANSFORM-HF. European Journal of Heart Failure. 2024;26(5):1242-1250. doi:10.1002/ejhf.3207
BibTeX
@article{Martens2024,
author = {Martens, Pieter and Greene, Stephen J and Mentz, Robert J and Li, Shuang and Wojdyla, Daniel and Kapelios, Chris J and Mullens, Wilfried and Hall, Michael E and Ketema, Fassil and Kim, Dong-Yun and Eisenstein, Eric L and Anstrom, Kevin and Fang, James C and Pitt, Bertram and Velazquez, Eric J and Tang, W H Wilson},
title = {Impact of Baseline Kidney Dysfunction on Oral Diuretic Efficacy Following Hospitalization for Heart Failure – Insights from TRANSFORM-HF},
journal = {European Journal of Heart Failure},
year = {2024},
volume = {26},
number = {5},
pages = {1242--1250},
doi = {10.1002/ejhf.3207}
}
EUVIMED